Safety and Efficacy of Dabigatran Reversal Agent Confirmed (FREE)

By Amy Orciari Herman Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD Idarucizumab — a humanized monoclonal antibody approved to reverse the anticoagulant effects of dabigatran — acts quickly and safely in emergency situations, according to final …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news